Centiva Capital, LP - IOVANCE BIOTHERAPEUTICS INC ownership

IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 240 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.2%.

Quarter-by-quarter ownership
Centiva Capital, LP ownership history of IOVANCE BIOTHERAPEUTICS INC
ValueSharesWeighting
Q1 2024$163,465
-47.8%
11,030
+11.4%
0.00%
-66.7%
Q1 2021$313,000
+34.9%
9,897
+97.8%
0.01%
+33.3%
Q4 2020$232,000
-11.1%
5,003
-65.1%
0.01%
-43.8%
Q3 2019$261,00014,3410.02%
Other shareholders
IOVANCE BIOTHERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
ACUTA CAPITAL PARTNERS, LLC 3,019,201$26,720,00020.38%
Broadfin Capital, LLC 5,951,153$52,668,0006.92%
GREAT POINT PARTNERS LLC 5,567,348$49,271,0006.23%
Avoro Capital Advisors LLC 10,261,039$90,810,0005.43%
FRAZIER MANAGEMENT LLC 2,188,331$19,367,0005.00%
Prosight Management, LP 1,062,500$9,403,0004.85%
Perceptive Advisors 12,241,111$108,333,0004.12%
Ghost Tree Capital, LLC 1,000,000$8,850,0003.21%
QVT Financial LP 1,021,361$8,696,0002.84%
Vivo Capital, LLC 1,600,000$14,160,0001.81%
View complete list of IOVANCE BIOTHERAPEUTICS INC shareholders